Company
United StatesPublic company, NYSE: SNNSmith & Nephew (NYSE: SNN), Woburn, MA – FDA Inspections
Inspection records and compliance data for Smith & Nephew in Woburn, Massachusetts. 1 FDA inspection on record, last inspected December 02, 2009. Publicly traded as NYSE: SNN.
Company Profile
This profile covers Smith & Nephew based in Woburn, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected December 2, 2009.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 2, 2009 | NAI | Biologics, Medical Devices & Rad Health · Human Cellular, Tissue, and Gene Therapies | 631527 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Smith & Nephew
Stock ticker
SNN
Exchange
NYSE
Share price
$32.03
Market cap
$13.4B
Price as of
November 6, 2026
FEI Number
3004833148
Address
165 New Boston St, Woburn, Massachusetts 01801, United States
Country
United States
ID: c7492e40-480d-4b8c-a53c-7fbabe8804fd